HomeCompareMRK vs ZION

MRK vs ZION: Dividend Comparison 2026

MRK yields 2.81% · ZION yields 3.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $26.3K in total portfolio value
10 years
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →
ZION
ZION
● Live price
3.20%
Share price
$55.59
Annual div
$1.78
5Y div CAGR
14.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.4K
Annual income
$1,892.05
Full ZION calculator →

Portfolio growth — MRK vs ZION

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMRKZION
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MRK + ZION cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MRK pays
ZION pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
ZION
Annual income on $10K today (after 15% tax)
$272.17/yr
After 10yr DRIP, annual income (after tax)
$1,608.24/yr
At 15% tax rate, MRK beats the other by $6,988.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRK + ZION for your $10,000?

MRK: 50%ZION: 50%
100% ZION50/50100% MRK
Portfolio after 10yr
$44.5K
Annual income
$6,002.91/yr
Blended yield
13.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
ZION
Analyst Ratings
17
Buy
32
Hold
1
Sell
Consensus: Hold
Price Target
$67.00
+20.5% upside vs current
Range: $60.00 — $75.00
Altman Z
-0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRK buys
0
ZION buys
0
No recent congressional trades found for MRK or ZION in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMRKZION
Forward yield2.81%3.20%
Annual dividend / share$3.32$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR32.7%14.7%
Portfolio after 10y$57.7K$31.4K
Annual income after 10y$10,113.78$1,892.05
Total dividends collected$29.8K$9.4K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$128.54$67.00

Year-by-year: MRK vs ZION ($10,000, DRIP)

YearMRK PortfolioMRK Income/yrZION PortfolioZION Income/yrGap
1← crossover$11,213$373.04$11,067$367.27+$146.00MRK
2$12,667$512.06$12,278$435.72+$389.00MRK
3$14,439$708.14$13,655$518.16+$784.00MRK
4$16,640$988.16$15,229$617.77+$1.4KMRK
5$19,432$1,394.07$17,034$738.54+$2.4KMRK
6$23,057$1,992.90$19,111$885.50+$3.9KMRK
7$27,889$2,894.79$21,514$1,065.02+$6.4KMRK
8$34,518$4,286.29$24,305$1,285.19+$10.2KMRK
9$43,912$6,494.35$27,563$1,556.42+$16.3KMRK
10$57,714$10,113.78$31,385$1,892.05+$26.3KMRK

MRK vs ZION: Complete Analysis 2026

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

ZIONStock

Zions Bancorporation, National Association provides various banking and related services primarily in the states of Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming. The company offers corporate banking services; commercial banking, including a focus on small- and medium-sized businesses; commercial real estate banking services; municipal and public finance services; retail banking, including residential mortgages; trust services; wealth management and private client banking services; and capital markets products and services. As of December 31, 2020, it operated 422 branches, which included 273 owned and 149 leased. The company was formerly known as ZB, National Association and changed its name to Zions Bancorporation, National Association in September 2018. Zions Bancorporation, National Association was founded in 1873 and is headquartered in Salt Lake City, Utah.

Full ZION Calculator →
📬

Get this MRK vs ZION comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRK vs JNJMRK vs ABBVMRK vs PFEMRK vs BMYMRK vs LLYMRK vs SCHDMRK vs JEPIMRK vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.